pyrroles has been researched along with Thrombocythemia, Essential in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostolidou, E; Borthakur, G; Burger, I; Kantarjian, H; Thomas, D; Verstovsek, S | 1 |
1 trial(s) available for pyrroles and Thrombocythemia, Essential
| Article | Year |
|---|---|
Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Topics: Aged; Antineoplastic Agents; Female; Humans; Indoles; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Pyrroles; Sunitinib; Thrombocythemia, Essential | 2010 |